Looks like Aspire will be the lucky recipient of discounted shares right now. If Oncosec is selling shares on this stock pop, let's just get the raise out of the way and let the market focus on data and not worry about cash for a while. Yesterdays AACR poster presentation is very positive for Oncosec going forward.
News 
Market Data 
Discover 
